Cancer Clinical Investigation

Search results

• BerGenBio ASA: Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations

  Rajwanth Veluswamy

  11/03/23

  1 item of Media coverage

  Press/Media

• FABA holding virtual workshop on drug discovery from March 13

  E. Premkumar Reddy

  11/03/23

  1 item of Media coverage

  Press/Media

• -BERGENBIO ANNOUNCES FIRST PATIENT DOSED IN PHASE 1B/2A TRIAL EVALUATING BEMCENTINIB IN 1ST LINE NON-SMALL CELL LUNG CANCER WITH STK11 MUTATIONS

  Rajwanth Veluswamy

  10/03/23

  2 items of Media coverage

  Press/Media

• Australia Patent: Icahn School of Medicine at Mount Sinai Files Application for 'Compositions and methods for treating EZH2-mediated cancer'

  ANQI MA , Jian Jin & Ramon Parsons

  25/03/22 → 10/03/23

  2 items of Media coverage

  Press/Media

• Australia Patent: Application for 'Serine threonine kinase (AKT) degradation / disruption compounds and methods of use' Lapses

  Xufen Yu, Jing Liu, Ramon Parsons & Jian Jin

  10/03/23

  1 item of Media coverage

  Press/Media

• Protagonist Therapeutics: More Good News Likely To Come

  Yelena Ginzburg

  9/03/23

  1 item of Media coverage

  Press/Media

• BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations

  Rajwanth Veluswamy

  9/03/23

  73 items of Media coverage

  Press/Media

• Bergenbio Announces First Patient Dosed In Phase 1B/2A Trial Evaluating Bemcentinib In 1St Line Non-Small Cell Lung Cancer With STK11 Mutations

  Rajwanth Veluswamy

  9/03/23

  32 items of Media coverage

  Press/Media

• CheckMate 274 follow up data boost nivolumab potential for high-risk bladder cancer

  Matthew Galsky

  8/03/23

  1 item of Media coverage

  Press/Media

• Dr. Galsky on the Rationale for the CheckMate-274 Trial in Urothelial Cancer

  Matthew Galsky

  8/03/23

  1 item of Media coverage

  Press/Media

• Dr. Mascarenhas on the Role of Pacritinib in Myelofibrosis

  John Mascarenhas

  8/03/23

  1 item of Media coverage

  Press/Media

• Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in …

  Oren Becher

  7/03/23

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Reports Findings in Depression (Stress-related reduction of hippocampal subfield volumes in major depressive disorder: A 7-Tesla study)

  Gaurav Verma, Hung-Mo Lin, Yael Jacob, Stephanie Brown, Lazar Fleysher, James Murrough, Patrick Hof & Priti Balchandani

  7/03/23

  1 item of Media coverage

  Press/Media

• Extended Follow-Up Reaffirms Benefit of Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma

  Matthew Galsky

  7/03/23

  1 item of Media coverage

  Press/Media

• Study Results from Icahn School of Medicine at Mount Sinai Update Understanding of Radiation Oncology (The Rise of Open Access Journals in Radiation Oncology: Influence on Resident Research, 2015 to 2019)

  Anthony Nehlsen, Eric Lehrer, Stanislav Lazarev, Kunal Sindhu, Brianna Jones & Michael Buckstein

  6/03/23

  1 item of Media coverage

  Press/Media

• Researchers develop novel approach to enhance drug delivery for brain tumours in children

  Oren Becher

  6/03/23

  1 item of Media coverage

  Press/Media

• Study Findings from Icahn School of Medicine at Mount Sinai Advance Knowledge in Radiation Oncology (Gender Differences in the Research Productivity of Radiation Oncology Resident Graduates in the United States: 2015 to 2019)

  Anthony Nehlsen, Eric Lehrer, Kunal Sindhu, Sheryl Green, Karyn Goodman & Brianna Jones

  6/03/23

  1 item of Media coverage

  Press/Media

• News Improved Tumor Drug Delivery Across Blood–Brain Barrier Researchers have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery of anti-cancer drugs to treat brain tumors in children.

  Oren Becher

  3/03/23

  2 items of Media coverage

  Press/Media

• Nanoparticles Target Medulloblastoma Tumor to Improve Drug Therapy and Reduce Toxicity

  Oren Becher

  3/03/23

  1 item of Media coverage

  Press/Media

• Scientists develop novel approach to enhance drug delivery for brain tumors in children

  Oren Becher

  2/03/23 → 3/03/23

  3 items of Media coverage

  Press/Media

• Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children

  Oren Becher

  2/03/23

  1 item of Media coverage

  Press/Media

• Mount Sinai Health System: Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children

  Oren Becher

  2/03/23

  1 item of Media coverage

  Press/Media

• Risk-Adapted Approach for Muscle-Invasive Bladder Cancer Requires Further Refinement

  Matthew Galsky

  1/03/23

  1 item of Media coverage

  Press/Media

• Studies from Icahn School of Medicine at Mount Sinai in the Area of Personalized Medicine Reported (The Combiome Hypothesis: Selecting Optimal Treatment for Cancer Patients)

  Fred Hirsch & Fred Hirsch

  27/02/23

  1 item of Media coverage

  Press/Media

• Researchers from University of Colorado Provide Details of New Studies and Findings in the Area of Squamous Cell Carcinoma (Egfr High Copy Number Together With High Egfr Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy ...)

  Fred Hirsch & Fred Hirsch

  27/02/23

  1 item of Media coverage

  Press/Media